Novel strategy for a bispecific antibody: induction of dual target internalization and degradation.
about
Bispecific Antibodies as a Development Platform for New Concepts and Treatment Strategies.The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancerBalancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) × c-MET Antibodies and Antibody-Drug Conjugates.ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment.Imaging EGFR and HER3 through 89Zr-labeled MEHD7945A (Duligotuzumab).A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancerDNA damaging agent-based antibody-drug conjugates for cancer therapy
P2860
Q34548319-5700E1B5-012B-4F86-9E4D-C51F9797FD8BQ42337044-844B218A-6FC2-456A-B281-9FB1D8C7AD37Q42499937-E3C373D1-192A-4A7B-902D-258893E30E8AQ46198687-388DB36D-463D-4276-A7D5-01DC01CDEF5EQ55384914-B27168BA-1B8B-48E3-874B-1FC7D719AAF6Q57162835-45D8B7F9-CD4E-46BF-90D8-DA17C20B0240Q57192403-686C437F-06A6-49DA-B20C-2D68BE265075
P2860
Novel strategy for a bispecific antibody: induction of dual target internalization and degradation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Novel strategy for a bispecifi ...... ternalization and degradation.
@en
Novel strategy for a bispecifi ...... ternalization and degradation.
@nl
type
label
Novel strategy for a bispecifi ...... ternalization and degradation.
@en
Novel strategy for a bispecifi ...... ternalization and degradation.
@nl
prefLabel
Novel strategy for a bispecifi ...... ternalization and degradation.
@en
Novel strategy for a bispecifi ...... ternalization and degradation.
@nl
P2093
P2860
P356
P1433
P1476
Novel strategy for a bispecifi ...... ternalization and degradation.
@en
P2093
K H Cheong
P2860
P2888
P304
P356
10.1038/ONC.2015.514
P407
P577
2016-02-08T00:00:00Z